The effect of problem-solving-based medication care training on pharmacological knowledge and medication error risk among pediatric nursing students: a quasi-experimental study. [PDF]
Hamzeluy M +3 more
europepmc +1 more source
Interprofessional Medication Error Disclosure Training Using a Telehealth Consultation Simulation. [PDF]
Baalmann A +8 more
europepmc +1 more source
Functional screening identified PcSyn14890, a cyanobacteria‐specific protein that enhances growth and stress resistance in E. coli and Synechocystis PCC6803. Although we expected it to function as a molecular chaperone, it was unable to protect against thermal aggregation of GAPDH.
Akiyo Yamada +7 more
wiley +1 more source
Knowledge, Attitudes, and Behaviors of Italian Home Care Nurses: Factors Associated with Medication Error Prevention in a Nationwide Cross-Sectional Survey. [PDF]
Dionisi S +10 more
europepmc +1 more source
A comprehensive method for the quantification of medication error probability based on fuzzy SLIM. [PDF]
Ghasemi F, Babamiri M, Pashootan Z.
europepmc +1 more source
Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley +1 more source
Utilization of Artificial Intelligence in Reducing the Incidence of Medication Error: A Bibliometric Analysis. [PDF]
Dino MJS +12 more
europepmc +1 more source
Existing Knowledge of Medication Error Must Be Better Translated Into Improved Patient Safety. [PDF]
Webster CS.
europepmc +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source

